Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 51Neoplasms 36Lung Neoplasms 25Colorectal Neoplasms 24Prostatic Neoplasms 15Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Rectal Neoplasms 9Pancreatic Neoplasms 9Hematologic Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Anxiety Disorders 9Obesity 8Lymphoma 8Depression 8Endometrial Neoplasms 7Vulvar Neoplasms 6Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Melanoma 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Pain 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Smoking Cessation 4Papillomavirus Infections 4

Interventions

Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chemotherapy-Induced Peripheral Neuropathy × Methods × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡